Prescott Group Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Buy |
869
+272
| +46% | +$121K | 0.05% | 231 |
|
|
2025
Q1 | $289K | Buy |
+597
| New | +$289K | 0.04% | 210 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$964K | – | 259 |
|
|
2018
Q3 | $964K | Hold |
5,000
| – | – | 0.19% | 120 |
|
|
2018
Q2 | $850K | Hold |
5,000
| – | – | 0.16% | 136 |
|
|
2018
Q1 | $815K | Hold |
5,000
| – | – | 0.18% | 131 |
|
|
2017
Q4 | $749K | Hold |
5,000
| – | – | 0.16% | 119 |
|
|
2017
Q3 | $760K | Buy |
+5,000
| New | +$760K | 0.15% | 120 |
|